Novartis’s Kisqali Strikes Gold In Adjuvant Early Breast Cancer Setting

$3bn More In Sales Projected

Two teapots, one with pink lid, one with no lid and dark hole, representing breasts and breast cancer
The Risk Of Breast Cancer Returning Peaks Three Years After Diagnosis • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

More from Anticancer

More from Therapeutic Category